Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 13 | 2024 | 214 | 5.800 |
Why?
|
| Glutens | 8 | 2024 | 83 | 3.430 |
Why?
|
| Interleukin-15 | 7 | 2020 | 73 | 2.150 |
Why?
|
| Intestinal Mucosa | 5 | 2021 | 805 | 1.760 |
Why?
|
| Adaptive Immunity | 3 | 2021 | 167 | 1.320 |
Why?
|
| HLA-DQ Antigens | 3 | 2021 | 51 | 1.060 |
Why?
|
| Self Tolerance | 1 | 2024 | 25 | 0.910 |
Why?
|
| Desensitization, Immunologic | 1 | 2024 | 37 | 0.900 |
Why?
|
| Autoimmune Diseases | 2 | 2024 | 249 | 0.870 |
Why?
|
| Autoantigens | 1 | 2024 | 129 | 0.860 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 2367 | 0.810 |
Why?
|
| Mice | 14 | 2024 | 11766 | 0.760 |
Why?
|
| Cell Communication | 2 | 2015 | 199 | 0.750 |
Why?
|
| Intestines | 2 | 2021 | 416 | 0.710 |
Why?
|
| Antigens | 3 | 2017 | 229 | 0.700 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 739 | 0.700 |
Why?
|
| HLA Antigens | 1 | 2021 | 227 | 0.690 |
Why?
|
| Th1 Cells | 3 | 2017 | 166 | 0.690 |
Why?
|
| Antigen-Presenting Cells | 4 | 2024 | 141 | 0.630 |
Why?
|
| Neutrophils | 4 | 2012 | 308 | 0.610 |
Why?
|
| Immunity, Innate | 2 | 2021 | 430 | 0.600 |
Why?
|
| Reoviridae Infections | 1 | 2017 | 7 | 0.580 |
Why?
|
| Mycobacterium bovis | 3 | 2008 | 16 | 0.570 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2015 | 319 | 0.570 |
Why?
|
| Animals | 19 | 2024 | 27387 | 0.560 |
Why?
|
| Atrophy | 3 | 2022 | 120 | 0.560 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 2343 | 0.540 |
Why?
|
| Intestine, Small | 2 | 2015 | 299 | 0.520 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2024 | 446 | 0.520 |
Why?
|
| Inflammation | 2 | 2021 | 971 | 0.510 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 178 | 0.490 |
Why?
|
| Mice, Transgenic | 5 | 2022 | 1575 | 0.470 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2014 | 275 | 0.440 |
Why?
|
| Stress, Physiological | 1 | 2015 | 232 | 0.440 |
Why?
|
| Signal Transduction | 4 | 2015 | 3387 | 0.410 |
Why?
|
| Epithelial Cells | 1 | 2015 | 689 | 0.370 |
Why?
|
| Lymphocytes | 1 | 2012 | 471 | 0.350 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 1224 | 0.340 |
Why?
|
| BCG Vaccine | 2 | 2010 | 35 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2021 | 596 | 0.330 |
Why?
|
| Vaccinia | 1 | 2008 | 3 | 0.330 |
Why?
|
| Hair Follicle | 1 | 2008 | 28 | 0.320 |
Why?
|
| Transglutaminases | 2 | 2021 | 40 | 0.320 |
Why?
|
| Interferon-gamma | 2 | 2021 | 451 | 0.310 |
Why?
|
| GTP-Binding Proteins | 2 | 2021 | 145 | 0.300 |
Why?
|
| Lymph Nodes | 5 | 2012 | 548 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 3220 | 0.300 |
Why?
|
| Nanostructures | 1 | 2008 | 79 | 0.300 |
Why?
|
| Vaccines | 1 | 2008 | 83 | 0.290 |
Why?
|
| Dendritic Cells | 2 | 2008 | 449 | 0.280 |
Why?
|
| Humans | 16 | 2024 | 89391 | 0.270 |
Why?
|
| Cell Movement | 2 | 2010 | 784 | 0.260 |
Why?
|
| Lymphatic System | 1 | 2005 | 55 | 0.250 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 2 | 2015 | 32 | 0.240 |
Why?
|
| Immune Tolerance | 2 | 2017 | 339 | 0.220 |
Why?
|
| Killer Cells, Natural | 2 | 2015 | 276 | 0.210 |
Why?
|
| Gliadin | 1 | 2022 | 17 | 0.210 |
Why?
|
| Antigen Presentation | 1 | 2024 | 215 | 0.210 |
Why?
|
| Autoimmunity | 1 | 2024 | 168 | 0.210 |
Why?
|
| Dinoprostone | 1 | 2021 | 70 | 0.190 |
Why?
|
| Homeostasis | 2 | 2014 | 417 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2021 | 105 | 0.180 |
Why?
|
| Interleukin-17 | 1 | 2021 | 105 | 0.180 |
Why?
|
| Up-Regulation | 2 | 2020 | 727 | 0.180 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 212 | 0.160 |
Why?
|
| Skin | 1 | 2021 | 583 | 0.150 |
Why?
|
| Reoviridae | 1 | 2017 | 6 | 0.150 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 19 | 0.150 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 20 | 0.140 |
Why?
|
| Genetic Engineering | 1 | 2017 | 115 | 0.140 |
Why?
|
| Interleukin-15 Receptor alpha Subunit | 1 | 2015 | 6 | 0.130 |
Why?
|
| Interferon Type I | 1 | 2017 | 185 | 0.130 |
Why?
|
| Myeloid Cells | 3 | 2012 | 100 | 0.130 |
Why?
|
| Leukotrienes | 1 | 2015 | 20 | 0.130 |
Why?
|
| Models, Immunological | 1 | 2015 | 81 | 0.130 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2015 | 33 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 1976 | 0.130 |
Why?
|
| Italy | 1 | 2015 | 108 | 0.120 |
Why?
|
| Cysteine | 1 | 2015 | 136 | 0.120 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 122 | 0.120 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 115 | 0.120 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 183 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2015 | 184 | 0.110 |
Why?
|
| Autoantibodies | 1 | 2015 | 268 | 0.110 |
Why?
|
| Phospholipases A2, Cytosolic | 1 | 2013 | 4 | 0.110 |
Why?
|
| Diet | 1 | 2017 | 442 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1863 | 0.110 |
Why?
|
| Arthritis, Psoriatic | 1 | 2013 | 34 | 0.110 |
Why?
|
| Lymphocyte Activation | 2 | 2021 | 751 | 0.110 |
Why?
|
| Dermis | 1 | 2012 | 28 | 0.110 |
Why?
|
| Risk Factors | 2 | 2015 | 5497 | 0.100 |
Why?
|
| Protein Binding | 1 | 2015 | 1488 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2012 | 163 | 0.100 |
Why?
|
| Female | 9 | 2021 | 46238 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2012 | 445 | 0.090 |
Why?
|
| Phenotype | 2 | 2015 | 2443 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 561 | 0.090 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2010 | 11 | 0.090 |
Why?
|
| Injections, Intradermal | 2 | 2009 | 19 | 0.090 |
Why?
|
| Polystyrenes | 1 | 2008 | 7 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2009 | 293 | 0.080 |
Why?
|
| Langerhans Cells | 1 | 2008 | 14 | 0.080 |
Why?
|
| Administration, Topical | 1 | 2008 | 96 | 0.080 |
Why?
|
| Immunity | 1 | 2009 | 141 | 0.080 |
Why?
|
| Receptors, CCR5 | 1 | 2008 | 18 | 0.080 |
Why?
|
| Chemokine CCL5 | 1 | 2008 | 16 | 0.080 |
Why?
|
| Cytokines | 2 | 2013 | 803 | 0.080 |
Why?
|
| Vaccines, DNA | 1 | 2008 | 18 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2010 | 279 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2008 | 68 | 0.080 |
Why?
|
| Virus Diseases | 1 | 2008 | 98 | 0.080 |
Why?
|
| Hybridomas | 1 | 2008 | 75 | 0.080 |
Why?
|
| Biological Transport | 1 | 2008 | 401 | 0.080 |
Why?
|
| Mycobacterium smegmatis | 2 | 2006 | 6 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 309 | 0.070 |
Why?
|
| Coculture Techniques | 1 | 2008 | 174 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2884 | 0.070 |
Why?
|
| Mycobacteriophages | 1 | 2006 | 1 | 0.070 |
Why?
|
| RNA, Transfer, Ala | 1 | 2006 | 1 | 0.070 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2006 | 3 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 169 | 0.070 |
Why?
|
| Virus Integration | 1 | 2006 | 16 | 0.070 |
Why?
|
| Antibodies, Viral | 1 | 2008 | 309 | 0.070 |
Why?
|
| Mycobacterium | 1 | 2006 | 18 | 0.070 |
Why?
|
| Cancer Vaccines | 1 | 2008 | 160 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2010 | 2002 | 0.070 |
Why?
|
| Male | 4 | 2021 | 42434 | 0.070 |
Why?
|
| Vaccination | 1 | 2008 | 275 | 0.070 |
Why?
|
| Neutrophil Activation | 1 | 2005 | 11 | 0.060 |
Why?
|
| Ear | 1 | 2005 | 17 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2005 | 168 | 0.060 |
Why?
|
| Proteolipids | 1 | 2003 | 8 | 0.060 |
Why?
|
| Glycopeptides | 1 | 2003 | 17 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 244 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2003 | 86 | 0.060 |
Why?
|
| United States | 1 | 2015 | 6999 | 0.050 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2021 | 3 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2021 | 68 | 0.050 |
Why?
|
| Macrophages | 1 | 2003 | 572 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 1088 | 0.040 |
Why?
|
| Colitis | 1 | 2021 | 244 | 0.040 |
Why?
|
| Receptors, Leukotriene | 1 | 2015 | 10 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2015 | 22 | 0.030 |
Why?
|
| Receptors, CCR1 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 911 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 691 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 557 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 64 | 0.020 |
Why?
|
| Vaccinia virus | 1 | 2009 | 19 | 0.020 |
Why?
|
| Cross-Priming | 1 | 2009 | 48 | 0.020 |
Why?
|
| Immunization | 1 | 2009 | 161 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1800 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2008 | 109 | 0.020 |
Why?
|
| Transformation, Bacterial | 1 | 2006 | 5 | 0.020 |
Why?
|
| Organisms, Genetically Modified | 1 | 2006 | 9 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2006 | 67 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 173 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 283 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2006 | 243 | 0.020 |
Why?
|
| Mycobacteriaceae | 1 | 2003 | 1 | 0.010 |
Why?
|
| Membrane Lipids | 1 | 2003 | 41 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 193 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 2327 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 313 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3027 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 26631 | 0.010 |
Why?
|